{"id":5693,"date":"2024-04-25T07:15:32","date_gmt":"2024-04-25T12:15:32","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5693"},"modified":"2025-06-27T11:19:33","modified_gmt":"2025-06-27T16:19:33","slug":"nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001\u30a2\u30ec\u30f3\u30fbC\u30fb\u30db\u30fc\u533b\u5b66\u535a\u58eb\u3092\u4e3b\u4efb\u533b\u7642\u9867\u554f\u306b\u4efb\u547d\u3057\u3001\u5909\u7570\u975e\u4f9d\u5b58\u578b\u7db2\u819c\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u5f37\u5316"},"content":{"rendered":"
\n
\n
\n

<\/h1>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>, 2024\u5e744\u670825\u65e5<\/span><\/span>\u00a0 \u2014 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e<\/a>\u7db2\u819c\u5909\u6027\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001 \u30a2\u30ec\u30f3\u30fbC\u30fb\u30db\u30fc<\/span>\u30db\u30fc\u535a\u58eb\u306f\u3001MD\u3001FACS\u3001FASRS \u306e\u8cc7\u683c\u3092\u6301\u3064\u3001\u6700\u9ad8\u533b\u7642\u9867\u554f\u3068\u3057\u3066\u3001\u907a\u4f1d\u5b50\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u6226\u7565\u306e\u7b56\u5b9a\u306b\u8ca2\u732e\u3057\u307e\u3059\u3002\u30db\u30fc\u535a\u58eb\u306f\u3001\u30a6\u30a3\u30eb\u30ba\u773c\u79d1\u75c5\u9662\u306e\u5916\u79d1\u533b\u517c\u7db2\u819c\u7814\u7a76\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308a\u3001\u30a6\u30a3\u30eb\u30ba\u773c\u79d1\u75c5\u9662\u7db2\u819c\u30b5\u30fc\u30d3\u30b9\u306e\u5171\u540c\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3082\u3042\u308a\u307e\u3059\u3002<\/p>\n

\u201c\u300c\u79c1\u305f\u3061\u306f\u30c9\u30af\u30bf\u30fc\u3092\u304a\u8fce\u3048\u3067\u304d\u308b\u3053\u3068\u3092\u5b09\u3057\u304f\u601d\u3063\u3066\u3044\u307e\u3059\u3002. \u30a2\u30ec\u30f3\u30fbC\u30fb\u30db\u30fc<\/span> \u300cNanoscope\u306b\u30c1\u30fc\u30d5\u30e1\u30c7\u30a3\u30ab\u30eb\u30a2\u30c9\u30d0\u30a4\u30b6\u30fc\u3068\u3057\u3066\u5165\u793e\u3059\u308b\u300d\u3068\u8ff0\u3079\u305f\u3002 \u30b9\u30e9\u30cb\u30e3\u30fb\u30d0\u30bf\u30c1\u30e3\u30ea\u30e4<\/span>, \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u5171\u540c\u5275\u696d\u8005\u517cCEO\u3067\u3042\u308b\u30db\u30fc\u535a\u58eb\u306f\u3001\u300c\u4e16\u754c\u7684\u306b\u8457\u540d\u306a\u7db2\u819c\u5c02\u9580\u533b\u3067\u3042\u308a\u3001\u7db2\u819c\u75be\u60a3\u306b\u5bfe\u3059\u308b\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u3001\u30db\u30fc\u535a\u58eb\u306e\u77e5\u898b\u306f\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306b\u3068\u3063\u3066\u975e\u5e38\u306b\u8cb4\u91cd\u306a\u3082\u306e\u3068\u306a\u308b\u3067\u3057\u3087\u3046\u3002MCO-010\u306f\u3001\u9032\u884c\u6027\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u60a3\u8005\u306b\u3068\u3063\u3066\u521d\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u3068\u306a\u308b\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u304a\u308a\u3001\u30db\u30fc\u535a\u58eb\u306e\u8ca2\u732e\u306f\u305d\u306e\u53ef\u80fd\u6027\u3092\u78ba\u5b9f\u306a\u3082\u306e\u306b\u3059\u308b\u4e0a\u3067\u5f79\u7acb\u3064\u3067\u3057\u3087\u3046\u3002\u307e\u305f\u3001\u6709\u671b\u306a\u7b2c2\u76f8\u81e8\u5e8a\u8a66\u9a13STARLIGHT\u306e\u7d50\u679c\u306b\u57fa\u3065\u304d\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u306b\u5bfe\u3059\u308bMCO-010\u306e\u958b\u767a\u306b\u3082\u30db\u30fc\u535a\u58eb\u306e\u8996\u70b9\u3092\u53d6\u308a\u5165\u308c\u308b\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u3068\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u201c<\/p>\n

\u201c\u300c\u904e\u53bb10\u5e74\u9593\u3001\u7db2\u819c\u75be\u60a3\u306b\u5bfe\u3059\u308b\u74b0\u5883\u5149\u611f\u53d7\u6027\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30af\u30b9\u6226\u7565\u306b\u53d6\u308a\u7d44\u3093\u3067\u304d\u305fNanoscope\u306e\u30c1\u30fc\u30e0\u30e1\u30f3\u30d0\u30fc\u3084\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3068\u3001\u3055\u3089\u306b\u7dca\u5bc6\u306b\u5354\u529b\u3067\u304d\u308b\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u300d\u3068Ho\u535a\u58eb\u306f\u8ff0\u3079\u305f\u3002\u300c\u6700\u8fd1\u767a\u8868\u3055\u308c\u305f2\u5e74\u9593\u306e\u30d5\u30a7\u30fc\u30ba 2b<\/span> RESTORE\u8a66\u9a13\u306e\u30c7\u30fc\u30bf\u306f\u7db2\u819c\u75be\u60a3\u6cbb\u7642\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u306b\u3068\u3063\u3066\u91cd\u8981\u306a\u7bc0\u76ee\u3067\u3042\u308a\u3001\u9032\u884c\u6027\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u82e6\u3057\u3080\u65b9\u3005\u306b\u3053\u306e\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u63d0\u4f9b\u3067\u304d\u308b\u3053\u3068\u3092\u5b09\u3057\u304f\u601d\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001Nanoscope\u793e\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3001\u7279\u306b\u52a0\u9f62\u9ec4\u6591\u5909\u6027\u75c7\u306b\u4f34\u3046\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\u60a3\u8005\u306e\u8996\u529b\u6539\u5584\u306b\u304a\u3051\u308b\u3001\u753b\u50cf\u8a98\u5c0e\u578b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u306b\u3088\u308bMCO-020\u6295\u4e0e\u306e\u81e8\u5e8a\u5fdc\u7528\u53ef\u80fd\u6027\u306b\u3082\u5927\u304d\u306a\u671f\u5f85\u3092\u5bc4\u305b\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u30a2\u30ec\u30f3\u30fbC\u30fb\u30db\u30fc<\/span>\u3001\u533b\u5b66\u535a\u58eb\u3001FACS\u3001FASRS
<\/b>\u30a2\u30ec\u30f3\u30fbC\u30fb\u30db\u30fc<\/span> MD\u3001FACS\u306f\u30a6\u30a3\u30eb\u30ba\u773c\u79d1\u75c5\u9662\u306e\u5916\u79d1\u533b\u3001\u7db2\u819c\u7814\u7a76\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001\u7db2\u819c\u30b5\u30fc\u30d3\u30b9\u306e\u5171\u540c\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308a\u3001\u773c\u79d1\u6559\u6388\u3067\u3042\u308b\u3002 \u30c8\u30fc\u30de\u30b9\u30fb\u30b8\u30a7\u30d5\u30a1\u30fc\u30bd\u30f3\u5927\u5b66<\/span> \u30db\u30fc\u535a\u58eb\u306f\u3001Mid Atlantic Retina \u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u3067\u3059\u3002\u9ec4\u6591\u75be\u60a3\u3001\u7cd6\u5c3f\u75c5\u6027\u7db2\u819c\u75c7\u3001\u5916\u79d1\u7684\u7db2\u819c\u75be\u60a3\u3001\u907a\u4f1d\u5b50\u30fb\u7d30\u80de\u7642\u6cd5\u3084\u65b0\u3057\u3044\u5916\u79d1\u7528\u85ac\u7269\u9001\u9054\u88c5\u7f6e\u30fb\u6280\u8853\u3092\u542b\u3080\u785d\u5b50\u4f53\u7db2\u819c\u75be\u60a3\u306e\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u3092\u8abf\u67fb\u3059\u308b\u81e8\u5e8a\u8a66\u9a13\u306b\u7279\u306b\u8208\u5473\u3092\u6301\u3063\u3066\u3044\u307e\u3059\u3002\u7814\u7a76\u30c7\u30b6\u30a4\u30f3\u3001\u65b9\u6cd5\u8ad6\u7684\u8a66\u9a13\u3001\u30c7\u30fc\u30bf\u5206\u6790\u3001\u5916\u79d1\u7528\u5668\u5177\u30fb\u624b\u9806\u958b\u767a\u3001\u3053\u308c\u3089\u306e\u7814\u7a76\u3068\u305d\u306e\u7814\u7a76\u7d50\u679c\u306e\u5b9f\u884c\u3068\u4f1d\u9054\u3001\u60a3\u8005\u306e\u6cbb\u7642\u3078\u306e\u30a2\u30af\u30bb\u30b9\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u305f\u5546\u54c1\u5316\u306e\u5c02\u9580\u77e5\u8b58\u3092\u5099\u3048\u305f\u5171\u540c\u30c8\u30e9\u30f3\u30b9\u30ec\u30fc\u30b7\u30e7\u30ca\u30eb\u7814\u7a76\u304a\u3088\u3073\u81e8\u5e8a\u8a66\u9a13\u306e\u81e8\u5e8a\u7814\u7a76\u306e\u7d4c\u9a13\u304c\u3042\u308a\u307e\u3059\u3002\u30db\u30fc\u535a\u58eb\u306f\u3001\u7c73\u56fd FDA \u773c\u79d1\u7528\u6a5f\u5668\u30d1\u30cd\u30eb\u3001\u7c73\u56fd\u773c\u79d1\u5b66\u4f1a (AAO) \u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30bf\u30b9\u30af\u30d5\u30a9\u30fc\u30b9\u3001AAO \u773c\u79d1\u7db2\u819c\u6280\u8853\u8a55\u4fa1\u59d4\u54e1\u4f1a\u3001AAO \u7db2\u819c\u6e2c\u5b9a\u30b0\u30eb\u30fc\u30d7\u3001AAO IRIS \u30ec\u30b8\u30b9\u30c8\u30ea\u59d4\u54e1\u4f1a\u3067\u6d3b\u8e8d\u3057\u3001\u4e16\u754c\u6700\u5927\u306e\u773c\u79d1\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u4f1a\u8b70\u3067\u3042\u308b Eyecelerator \u306e\u30ea\u30fc\u30c0\u30fc\u3067\u3082\u3042\u308a\u307e\u3059\u3002<\/p>\n

Nanoscope Therapeutics, Inc. \u306b\u3064\u3044\u3066
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306f\u3001\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u3067\u5931\u660e\u3057\u305f\u6570\u767e\u4e07\u4eba\u306e\u60a3\u8005\u306b\u5bfe\u3057\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u3002\u3053\u308c\u3089\u306e\u75be\u60a3\u306b\u306f\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u3002\u540c\u793e\u306e\u4e3b\u8981\u958b\u767a\u5019\u88dc\u3067\u3042\u308bMCO-010\u306f\u3001\u6700\u8fd1\u3001RESTORE\u30d5\u30a7\u30fc\u30ba\u306e\u4e3b\u8981\u7d50\u679c\u3092\u767a\u8868\u3057\u305f\u3002 2b<\/span>\/3 \u7c73\u56fd\u306b\u304a\u3051\u308b\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u5bfe\u3059\u308b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\uff08NCT04945772<\/a>\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u306e\u8a66\u9a13\u7d42\u4e86\u8a2a\u554f\u3092\u6700\u8fd1\u5b8c\u4e86\u3057\u305f\uff08NCT05417126<\/a>MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u75c5\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068FDA\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001 www.nanostherapeutics.com<\/a> \u305d\u3057\u3066\u5f7c\u3089\u3092\u30d5\u30a9\u30ed\u30fc\u3059\u308b \u30ea\u30f3\u30af\u30c8\u30a4\u30f3<\/a>.<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
212-600-1902
PR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

DALLAS, April 25, 2024\u00a0 \u2014 Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced today the appointment of Allen C. Ho, MD, FACS, FASRS, as Chief Medical Advisor, where he will help define the strategy of developing the gene mutation-agnostic therapies. Dr. Ho is Attending Surgeon and Director of Retina Research at Wills Eye Hospital and Co-Director of the Wills Eye Hospital Retina Service. \u201cWe are excited to have Dr. Allen C. Ho join Nanoscope as Chief Medical Advisor,\u201d said Sulagna Bhattacharya, Nanoscope co-founder and CEO. \u201cAs a world-renowned retina specialist and leader in innovative treatments for retinal diseases, his insight will be invaluable […]<\/p>\n","protected":false},"author":6,"featured_media":5694,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5693","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-25T12:15:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:19:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_AllenHo_V3REV.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_AllenHo_V3REV.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor\",\"datePublished\":\"2024-04-25T12:15:32+00:00\",\"dateModified\":\"2025-06-27T16:19:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/\"},\"wordCount\":586,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/NSCOPE_LI_AllenHo_V3REV.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/\",\"name\":\"Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/NSCOPE_LI_AllenHo_V3REV.jpg\",\"datePublished\":\"2024-04-25T12:15:32+00:00\",\"dateModified\":\"2025-06-27T16:19:33+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/NSCOPE_LI_AllenHo_V3REV.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/NSCOPE_LI_AllenHo_V3REV.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/04\\\/25\\\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30a2\u30ec\u30f3\u30fbC\u30fb\u30db\u30fc\u533b\u5e2b\u3092\u6700\u9ad8\u533b\u7642\u9867\u554f\u306b\u4efb\u547d\u3057\u3001\u5909\u7570\u975e\u4f9d\u5b58\u578b\u7db2\u819c\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u5f37\u5316 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-04-25T12:15:32+00:00","article_modified_time":"2025-06-27T16:19:33+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_AllenHo_V3REV.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_AllenHo_V3REV.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor","datePublished":"2024-04-25T12:15:32+00:00","dateModified":"2025-06-27T16:19:33+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/"},"wordCount":586,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_AllenHo_V3REV.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/","url":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30a2\u30ec\u30f3\u30fbC\u30fb\u30db\u30fc\u533b\u5e2b\u3092\u6700\u9ad8\u533b\u7642\u9867\u554f\u306b\u4efb\u547d\u3057\u3001\u5909\u7570\u975e\u4f9d\u5b58\u578b\u7db2\u819c\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u5f37\u5316 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_AllenHo_V3REV.jpg","datePublished":"2024-04-25T12:15:32+00:00","dateModified":"2025-06-27T16:19:33+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_AllenHo_V3REV.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/04\/NSCOPE_LI_AllenHo_V3REV.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/04\/25\/nanoscope-therapeutics-enhances-mutation-independent-retinal-gene-therapy-programs-with-appointment-of-allen-c-ho-md-as-chief-medical-advisor\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD, as Chief Medical Advisor"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5693"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5693\/revisions"}],"predecessor-version":[{"id":9049,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5693\/revisions\/9049"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5694"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}